Patent details

EP2397158 Title: Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect

Basic Information

Publication number:
EP2397158
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP111806030
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect
French Title of Invention:
Combinaison de composés de morphinane et d'antidépresseur pour le traitement de l affect pseudobulbaire
German Title of Invention:
Kombination von Morphinan-Verbindungen und Antidepressiva zur Behandlung von pseudobulbärem Affekt
SPC Number:

Dates

Filing date:
30/10/2009
Grant date:
13/04/2016
EP Publication Date:
13/04/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/12/2011
EP B1 Publication Date:
13/04/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/10/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/10/2009
 
 

Name:
CONCERT PHARMACEUTICALS INC.
Address:
99 Hayden Avenue, Suite 100, Lexington, MA 02421, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
25/04/2016
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
Thomas Amanda
Address:
United States (US)

Priority

Priority Number:
109832 P
Priority Date:
30/10/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 45/06;

Annual Fees

Annual Fee Due Date:
31/10/2025
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
25/10/2024
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56